CEBPZ and acute myeloid leukemia: Among baseline parameters, CBF-AML status at HMA initiation (diagnosis vs. hematological relapse vs. molecular relapse or progression), platelets count (per 10 G/L) and medullar blast percentage were associated with OS in univariate analysis (p < 0.1) (Supplemental Table 1).